Clinical Trial Update: Inhaled Steroid Reduces Systemic Inflammation in COPD [Phase 4]

View source ↗

Summary

A Phase 4 trial found that an inhaled corticosteroid reduces systemic inflammation in chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• Inhaled corticosteroid (inhaled corticosteroid)

Snippet

Sponsor: University of British Columbia | Conditions: Chronic Obstructive Pulmonary Disease, Emphysema | Phase 4 | Status: COMPLETED